Clinical Trials Browser

Phase 1/2 × Corticotropin-Releasing Hormone × Clear all

NCT01369121 2013-07-30

Tolerability Study of Xerecept® in Pediatric Patients

Phase 1/2 Terminated

Brain Edema, Brain Neoplasms, Edema